首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1425072

脊髓刺激市場：預測（2024-2029）

Spinal Cord Stimulation Market - Forecasts from 2024 to 2029

出版日期: 2024年01月22日 | 出版商:

Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

2022 年脊髓刺激市值為 24.28 億美元。

細電纜（電極）和類似心律調節器的小型電池組構成了脊髓刺激療法。發生器放置在皮下，通常靠近臀部或胃部，電極放置在脊髓與脊椎骨交匯處的硬膜外腔。遙控器的天線也位於機身外部。

全球老年人口不斷增加

由於人口老化，脊髓刺激治療市場預計將更加迅速地擴大。據世界衛生組織稱，到2050年，大約有15億人將超過65歲，其中大多數人將生活在新興國家。在全球範圍內，人們的壽命越來越長。現在大多數人預計能活到 60 多歲甚至更久。地球上每個國家的老年人口數量和比例都在增加。

到 2030 年，地球上六分之一的人將超過 60 歲。此時，60歲及以上人口比例將從2020年的10億增加到14億。因此，更容易患神經系統疾病等慢性疾病的人口老化正在推動脊髓刺激治療市場的成長。

複雜性局部疼痛症候群的盛行率增加

膚色和體溫的變化也是複雜性局部疼痛症候群的症狀。所有這些變化都是由於調節血流和體溫的神經受損而引起的微循環異常的結果。有些人可能會因外傷或受傷而出現軟組織損傷、扭傷、骨折、四肢無法活動或出現上述所有情況。退化性疾病預計將以最快的速度發展，並推動脊髓刺激市場的發展。

提高脊髓刺激療法的意識

隨著個人和醫療保健專業人員對脊髓刺激治療設備的認知不斷提高，脊髓刺激治療產業預計將會成長。隨著患者越來越意識到脊髓刺激的好處，醫療保健專業人員正在推廣脊髓刺激作為慢性疼痛和其他脊椎疾病的可行治療選擇。透過政府和保險公司提供的各種報銷計劃，患者可以負擔得起脊髓刺激治療設備。

微創方法和無線技術日益普及

脊髓刺激療法擴大採用微創方法進行植入。這些方法縮短了恢復期，減少了手術創傷，並提高了患者的舒適度。此外，無線技術的進步使得遠端控制脊髓刺激治療成為可能。使用外部設備和智慧型手機應用程式，患者可以自訂設備設定並使疼痛治療變得更容易。這是脊髓刺激治療市場的關鍵促進因素。

技術改進

隨著脊髓刺激設備技術的發展，脊髓刺激產業正在不斷擴大。新的小工具添加了最新功能，包括更長的電池壽命、改進的編程等等。這些發展正在推動脊髓刺激治療設備的使用，以改善患者的治療效果。醫療設備產業為滿足許多目標市場未滿足的醫療需求而推出的創新脊髓刺激治療設備預計將為脊髓刺激治療市場的成長提供利潤豐厚的機會。

人工智慧在脊髓刺激治療的應用

脊髓刺激療法使用人工智慧來提高刺激器發送的電脈衝的準確性。這是透過持續追蹤和收集有關患者健康狀況的資訊並使用該資訊來更改刺激器的設定來實現的。這可能會實現更個人化的治療策略，並最終改善患者的治療結果。透過使用人工智慧也可以減少與現有脊髓刺激療法相關的副作用，這是脊髓刺激市場的關鍵成長要素。人工智慧被用來識別疾病、預測患者的治療結果，甚至提案個人化的治療計畫。

在北美，脊髓刺激治療市場預計將穩定成長。

由於慢性疼痛、下背痛和 CRPS 的發病率不斷增加，預計北美將佔據全球脊髓刺激治療市場的大部分。此外，成熟的醫療設施、高素質醫生的存在以及對脊髓刺激療法的認知不斷提高也推動了北美市場的發展。此外，由於技術改進產品的快速採用，預計脊髓刺激治療市場也將快速成長。

美國預計將佔最大市場佔有率

美國是北美地區最大的脊髓刺激治療行業，該行業的成長預計將受到產品發布以及與主要製造商和其他公司的商業化協議增加的推動。例如，波士頓科學公司最近推出的 WaveWriter Alpha 系列 SCS 設備預計將在 2021 年 1 月推動脊髓刺激療法 (SCS) 市場的成長。

Thin cables (the electrodes) and a tiny battery pack resembling a pacemaker make up spinal cord stimulators. The generator is positioned beneath the skin, often close to the buttocks or belly, and the electrodes are positioned in the epidural space, which is where the spinal cord and vertebrae meet. The remote control's antenna is also external to the body.

Growing geriatric population globally

The spinal cord stimulation market is expected to expand more quickly due to the aging population. Around 1.5 billion people will reach 65 years of age or older by 2050, according to the World Health Organization, with emerging countries contributing the majority of this rise. Globally, people are living longer. Today, the majority of individuals may anticipate living into their 60s and beyond. The number of older people and their share of the population are increasing in every nation on earth.

One in six individuals on the planet will be 60 or older by 2030. At this period the percentage of the population aged 60 years and older will climb from 1 billion in 2020 to 1.4 billion. Therefore, the aging population, which is more prone to chronic illnesses such as neurological diseases, is what is driving the spinal cord stimulation market growth.

Increasing prevalence of complex regional pain syndrome

Changes in skin tone and temperature are other symptoms of complex regional pain syndrome. All of these alterations are the result of aberrant microcirculation brought on by nerve injury that regulates blood flow and body temperature. Some people experience trauma or injury that results in soft tissue damage, sprains, fractures, limb immobilization, or all of the above. The degenerative disc disease is anticipated to develop at the quickest rate and fuel the spinal cord stimulation market.

Increase in awareness of spinal cord stimulation

The spinal cord stimulation industry is anticipated to grow as individuals and healthcare professionals become more aware of spinal cord stimulation devices. Healthcare professionals are advising these devices as a realistic therapy option for chronic pain and other spinal problems as patients are becoming more aware of their advantages. The cost of spinal cord stimulation devices has decreased for patients due to various reimbursement programs offered by several governments and insurance companies.

Rising popularity for minimally invasive approaches and wireless technologies

Spinal cord stimulators are increasingly being implanted using minimally invasive methods. These methods shorten recuperation durations, lessen surgical trauma, and improve patient comfort. Additionally, wireless technological advancements have made it possible to remotely program spinal cord stimulators. With the use of external devices or smartphone applications, patients may customize their device's settings for more easy pain treatment. This plays a key driver for the spinal cord stimulation market.

Enhancement in Technology

The spinal cord stimulation industry is expanding due to technical developments in spinal cord stimulation devices. Modern features like longer battery life, and better programming are being added to new gadgets. These developments are boosting the use of spinal cord stimulation devices and enhancing patient outcomes. Innovative spinal cord stimulation devices being introduced by the medical device sector to meet the unmet medical demands of a sizable target audience are anticipated to offer profitable chances for spinal cord stimulation market growth.

Use of AI in spinal cord stimulation

In spinal cord stimulation, AI is being utilized to improve the accuracy of the electrical impulses delivered by the stimulator. This is accomplished by continuously tracking and gathering information about the patient's health, and utilizing that information to modify the stimulator's settings. This enables a more individualized treatment strategy and could ultimately improve patient results. The number of adverse effects connected to existing spinal cord stimulator therapies may also be decreased with the use of AI which is a major growth driver for the spinal cord stimulation market. AI is being used to identify illnesses, forecast patient outcomes, and even suggest individualized treatment plans.

In North America, it is projected that the spinal cord stimulation market would grow steadily.

North America is anticipated to dominate the worldwide spinal cord stimulation market due to an increase in occurrences of chronic pain, failing back syndrome, and CRPS. Additionally, the existence of well-established healthcare facilities, the availability of highly qualified doctors, and rising awareness of spinal cord stimulation therapy will propel the North American market. Rapid spinal cord stimulation market growth is also anticipated as a result of the rapid adoption of technologically improved items.

The United States is anticipated to hold the maximum market share

The United States is the largest spinal cord stimulation industry in the North American region, and this industry's growth is predicted to be boosted by increased product launches and commercialization agreements with important manufacturers and other businesses. For instance, the spinal cord stimulation market growth of spinal cord stimulators (SCS) is anticipated to be boosted in January 2021 by the recent launch of Boston Scientific's WaveWriter Alpha line of SCS devices.

Market Key Developments

In May 2023, according to a statement from Abbott, the U.S. Food and Drug Administration (FDA) authorized the use of its spinal cord stimulation (SCS) devices to treat people with persistent back pain.
In October 2022, The Senza HFX iQ spinal cord stimulation (SCS) device, which includes AI, was authorized by the FDA.
In August 2022, the new ProclaimTM Plus spinal cord stimulation (SCS) device from Abbott, which uses FlexBurst360TM treatment, gained FDA clearance.
In January 2022, The U.S. Food and Drug Administration has approved the use of the rechargeable neurostimulators IntellisTM and VantaTM by Medtronic plc, a world leader in healthcare technology, to treat chronic pain brought on by diabetic peripheral neuropathy (DPN).

Segmentation:

By Product

Rechargeable
Non-rechargeable

By Disease Indication

Failed Back Surgery Syndrome
Degenerative Disc Disease
Complex Regional Pain Syndrome
Arachnoiditis
Others

By End-User

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. SPINAL CORD STIMULATION MARKET, BY PRODUCT

5.1. Introduction
5.2. Rechargeable
5.3. Non-rechargeable

6. SPINAL CORD STIMULATION MARKET, BY DISEASE INDICATION

6.1. Introduction
6.2. Failed Back Surgery Syndrome
6.3. Degenerative Disc Disease
6.4. Complex Regional Pain Syndrome
6.5. Arachnoiditis
6.6. Others

7. SPINAL CORD STIMULATION MARKET, BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Specialty Clinics

8. SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others